ES2613753T3 - Proceso para la preparación de derivados de esterol - Google Patents
Proceso para la preparación de derivados de esterol Download PDFInfo
- Publication number
- ES2613753T3 ES2613753T3 ES12788589.5T ES12788589T ES2613753T3 ES 2613753 T3 ES2613753 T3 ES 2613753T3 ES 12788589 T ES12788589 T ES 12788589T ES 2613753 T3 ES2613753 T3 ES 2613753T3
- Authority
- ES
- Spain
- Prior art keywords
- vol
- integer
- formula
- same
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306548 | 2011-11-24 | ||
| EP11306548 | 2011-11-24 | ||
| PCT/EP2012/073489 WO2013076257A1 (en) | 2011-11-24 | 2012-11-23 | Process for the preparation of sterol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2613753T3 true ES2613753T3 (es) | 2017-05-25 |
Family
ID=47216329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12788589.5T Active ES2613753T3 (es) | 2011-11-24 | 2012-11-23 | Proceso para la preparación de derivados de esterol |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9447141B2 (show.php) |
| EP (1) | EP2782923B1 (show.php) |
| JP (1) | JP6157492B2 (show.php) |
| KR (1) | KR20140098131A (show.php) |
| CN (1) | CN104039807B (show.php) |
| AU (1) | AU2012342460B2 (show.php) |
| BR (1) | BR112014012458A2 (show.php) |
| CA (1) | CA2856609C (show.php) |
| ES (1) | ES2613753T3 (show.php) |
| IN (1) | IN2014MN00976A (show.php) |
| MX (1) | MX343787B (show.php) |
| RU (1) | RU2014125435A (show.php) |
| WO (1) | WO2013076257A1 (show.php) |
| ZA (1) | ZA201403736B (show.php) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015106164A1 (en) | 2014-01-10 | 2015-07-16 | Rgenix, Inc. | Lxr agonists and uses thereof |
| JP7025022B2 (ja) | 2016-01-11 | 2022-02-24 | ザ ロックフェラー ユニバーシティー | 骨髄系由来抑制細胞関連障害の治療のための方法 |
| FR3064470A1 (fr) * | 2017-03-31 | 2018-10-05 | Lessonia | Masque ou patch prepare a partir d’une composition d’alginate |
| CA3078981A1 (en) | 2017-11-21 | 2019-05-31 | Rgenix, Inc. | Polymorphs and uses thereof |
| MA53666A (fr) * | 2018-09-19 | 2021-07-28 | Modernatx Inc | Purification de stérol |
| BE1027157B9 (fr) * | 2019-08-01 | 2020-11-03 | Dendrogenix | Composition de dérivés de stérols pour son utilisationdans le traitement d’une pathologie neuronale liée à une hypoxie et/ou à une hypoglycémie et composition correspondante |
| JP7689964B2 (ja) | 2019-12-13 | 2025-06-09 | インスピルナ，インコーポレーテッド | 金属塩及びその使用 |
| BE1028852B1 (fr) * | 2020-12-03 | 2022-07-05 | Dendrogenix | PRODROGUE DU 5α-hydroxy-6β-[2-(1H-imidazol-4-yl) éthylamino]cholestan-3β-ol ET COMPOSITIONS PHARMACEUTIQUES LE COMPRENANT POUR UTILISATION DANS LE TRAITEMENT DU CANCER |
| EP4236963A1 (fr) * | 2020-10-29 | 2023-09-06 | Dendrogenix | Analogues du 5alpha-hydroxy-6 beta-[2-(1-h-imidazol-4-yl)ethylamino]-cholestan-3 beta-ol et compositions pharmaceutiques le comprenant pour utilisation dans le traitement du cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2838741B1 (fr) | 2002-04-19 | 2006-01-27 | Inst Nat Sante Rech Med | Derives de sterols, leur procede de preparation et medicaments les comportant |
-
2012
- 2012-11-23 KR KR1020147016187A patent/KR20140098131A/ko not_active Withdrawn
- 2012-11-23 WO PCT/EP2012/073489 patent/WO2013076257A1/en not_active Ceased
- 2012-11-23 EP EP12788589.5A patent/EP2782923B1/en active Active
- 2012-11-23 JP JP2014542857A patent/JP6157492B2/ja active Active
- 2012-11-23 CA CA2856609A patent/CA2856609C/en active Active
- 2012-11-23 US US14/359,658 patent/US9447141B2/en active Active
- 2012-11-23 ES ES12788589.5T patent/ES2613753T3/es active Active
- 2012-11-23 IN IN976MUN2014 patent/IN2014MN00976A/en unknown
- 2012-11-23 BR BR112014012458A patent/BR112014012458A2/pt not_active IP Right Cessation
- 2012-11-23 CN CN201280065737.0A patent/CN104039807B/zh active Active
- 2012-11-23 RU RU2014125435/04A patent/RU2014125435A/ru not_active Application Discontinuation
- 2012-11-23 AU AU2012342460A patent/AU2012342460B2/en active Active
- 2012-11-23 MX MX2014006303A patent/MX343787B/es active IP Right Grant
-
2014
- 2014-05-22 ZA ZA2014/03736A patent/ZA201403736B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140309417A1 (en) | 2014-10-16 |
| ZA201403736B (en) | 2015-11-25 |
| JP2015502934A (ja) | 2015-01-29 |
| JP6157492B2 (ja) | 2017-07-05 |
| CA2856609A1 (en) | 2013-05-30 |
| US9447141B2 (en) | 2016-09-20 |
| EP2782923A1 (en) | 2014-10-01 |
| KR20140098131A (ko) | 2014-08-07 |
| MX343787B (es) | 2016-10-31 |
| IN2014MN00976A (show.php) | 2015-04-24 |
| BR112014012458A2 (pt) | 2017-06-06 |
| MX2014006303A (es) | 2014-09-08 |
| AU2012342460A1 (en) | 2014-06-12 |
| CN104039807A (zh) | 2014-09-10 |
| CA2856609C (en) | 2021-01-12 |
| EP2782923B1 (en) | 2016-11-23 |
| RU2014125435A (ru) | 2015-12-27 |
| AU2012342460B2 (en) | 2017-06-29 |
| WO2013076257A1 (en) | 2013-05-30 |
| CN104039807B (zh) | 2018-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2613753T3 (es) | Proceso para la preparación de derivados de esterol | |
| ES2624795T3 (es) | Derivados de N-(heteroaril)-1-heteroaril-1H-indol-2-carboxamidas, su preparación y su aplicación en terapéutica | |
| ES2660051T3 (es) | Compuestos heterocíclicos condensados como inhibidores selectivos de BMP | |
| ES2585221T3 (es) | Un proceso para la preparación de 6-(7-((1-aminociclopropil)metoxi)-6-metoxiquinolin-4-iloxi)-n-metil-1-naftamida y productos intermedios sintéticos de la misma | |
| CU20170155A7 (es) | Un compuesto de quelato de gadolinio, un proceso para usar su preparación y compuestos intermediarios para la preparación del mismo | |
| AR068681A1 (es) | Inhibidores cristalinos peptidicos de epoxi cetona proteasa y la sintesis de ceto - epoxidos de aminoacidos | |
| RU2010141941A (ru) | Способ получения фторсодержащего производного ацилуксусной кислоты, способ получения фторсодержащего производного сложного эфира пиразолкарбоновой кислоты и способ получения фторсодержащего пиразолкарбоновой кислоты | |
| JP2012532135A5 (show.php) | ||
| AR091176A1 (es) | Pirrodilina-2-carboxamidas sustituidas | |
| PA8783601A1 (es) | Derivados de piperidina/piperazina | |
| JP2014507383A5 (show.php) | ||
| AR087771A1 (es) | Moduladores de la pde10 | |
| AR057032A1 (es) | Tigeciclina y metodos de preparacion | |
| JP2019210289A (ja) | レッドシフトを有する新規なベンゾトリアゾール紫外線吸収剤及びその用途 | |
| AR075177A1 (es) | Derivados de tiadiazoles y oxadiazoles, metodo de preparacion, intermediarios de sintesis, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad y diabetes, entre otros. | |
| AR077301A1 (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano como antagonistas de 5-ht1a y 5-ht1b | |
| AR091075A1 (es) | Proceso para preparar derivados monociclicos de heteroaril-cicloalquil-diamina | |
| AR054277A1 (es) | Derivados de piperidin - 4 - il - amida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con la modulacion de receptores del subtipo 5 de la sst. | |
| CN102040617B (zh) | 有机二氟化硼配合物及其制备方法 | |
| EP2319842A1 (en) | Fluorescent carbazole compounds for cancer diagnosis | |
| CN106348993B (zh) | 应用于三重态-三重态湮灭上转换体系的湮灭剂及其制备与应用方法 | |
| MX2021013574A (es) | Sintesis de imidazo[1,2-a]pirimidinas etiquetadas. | |
| CN113185967B (zh) | 近红外磷光发射材料及其制备方法和应用 | |
| ES2615729T3 (es) | Proceso para preparar 3-haloalquilpirazoles | |
| JP6915097B2 (ja) | 組成物、硬化性組成物および化合物 |